Impact of <scp> CD33 </scp> and <scp> ABCB1 </scp> single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin

Authors :: Ioannis Papageorgiou
Tapan M. Kadia
Naveen Pemmaraju
Guillaume Richard-Carpentier
Rashmi Kanagal-Shamanna
Courtney D. DiNardo
Farhad Ravandi
Gautam Borthakur
Keyur P. Patel
Hagop M. Kantarjian
Jatinder K. Lamba
Nicholas J. Short
Marina Konopleva
Naval Daver
Source :: American Journal of Hematology. 95
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: Oncology
medicine.medical_specialty
Myeloid
Gemtuzumab ozogamicin
business.industry
CD33
Decitabine
Myeloid leukemia
Single-nucleotide polymorphism
Hematology
medicine.anatomical_structure
Internal medicine
medicine
In patient
business
medicine.drug

Full Text Access

Tools